The main barrier in the progress of clinical gene therapy is the absence of a safe and efficient vector system with regulatable and tissue-specific characteristics. However, progress has been made in ...

Gene therapy aims to treat both genetic and infectious diseases via introduction of new genetic material into the appropriate cells in the body. One of the greatest challenges of gene therapy is ...

The “outdated” downstream separation technologies used in viral vector manufacturing are a major cause of the industry’s struggles to keep up with growing demand from the gene therapy sector. At least ...